Publications by authors named "Charlene So"

Claim this Profile
H
High rates of durable response are achieved with imatinib after treatment with interferon alpha plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial.
François Guilhot, Brian Druker, Richard A Larson, Insa Gathmann, Charlene So

Haematologica· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.
Michael W N Deininger, Jorge Cortes, Ron Paquette, Byung Park, Andreas Hochhaus, Charlene So

Cancer· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
Brian J Druker, François Guilhot, Stephen G O'Brien, Insa Gathmann, Hagop Kantarjian, Bengt Simonsson, Charlene So, Richard A Larson

N Engl J Med· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials.
Lydia Roy, Joëlle Guilhot, Tillmann Krahnke, Agnès Guerci-Bresler, Brian J Druker, Richard A Larson, Charlene So

Blood· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis